The Repair Architecture : Post 4 : The Letter Post 4 Subtitle : A denied exemption request didn’t end the story. It started a different one — and rewrites where this series began.

The Repair Architecture · Post 4 of 7

The Letter

A denied exemption request didn't end the story. It started a different one — and rewrites where this series began.

Randy Gipe · Claude / Anthropic · 2026 · Trium Publishing House Limited
Sub Verbis · Vera

This post requires a correction to the record this series has built so far, and the correction matters enough to state plainly before going further: the therapeutic use exemption at the center of this story was not denied by the current CSAD/DFSI structure examined in Posts 2 and 3. It was denied by USADA — and according to the New York Times, that denial is the event that set the rupture in Post 1 into motion. The letter came first. The split came after.

What Actually Happened, in Order

Conor McGregor broke his tibia and fibula in July 2021. Dr. Neal ElAttrache, the Dodgers' and Rams' head team physician, oversaw the surgical repair. By his own account to the Times, ElAttrache grew concerned the fracture wasn't healing correctly and referred McGregor to outside specialists in bone metabolism — physicians he says he chose deliberately to keep at arm's length from his own role. "I purposely wasn't involved with his evaluation by the consultant nor with prescribing medication," he told the paper.

One of those consultants did prescribe a banned substance, with the stated goal of improving bone healing. ElAttrache then wrote a letter supporting McGregor's application to USADA for a therapeutic use exemption — a formal request to use that substance without penalty, on medical grounds. USADA denied it.

Jul 2021 McGregor's leg fracture; ElAttrache oversees surgery

2021–2022 ElAttrache refers McGregor to bone-healing consultants; a consultant prescribes a banned substance

2022–2023 ElAttrache writes a letter supporting a TUE application; USADA denies it

2023 McGregor "retires" from the UFC — a procedural exit that removes him from the USADA testing pool entirely

Oct 8, 2023 McGregor re-enters the testing pool the same day UFC notifies USADA it is ending the partnership

Jun 2026 New York Times publishes the letter and ElAttrache's account; MLB schedules an informational interview

Read this way, Post 1's "rupture" is not a standalone institutional dispute over a six-month re-entry rule. It's the second-order consequence of a denied medical exemption. The six-month rule was the proximate flashpoint USADA cited publicly. The TUE denial is what the Times reports actually got things moving. Both can be true at once — institutions rarely collapse over one clean cause — but the letter belongs earlier in this story's spine than this series initially placed it.

Correction to Post 1: this series did not have the TUE denial in hand when "The Rupture" was drafted. It is added here rather than retroactively edited into that post, consistent with this archive's practice of correcting forward rather than rewriting the record.

The Defense, in ElAttrache's Own Words

ElAttrache has not denied writing the letter. His defense is narrower and more precise than the white paper's framing suggested: he disputes the implication that "banned" means "illegitimate."

"You are acting as if 'banned drugs' are somehow 'illegal drugs,' or that they have no legitimate therapeutic use and only have performance enhancement use. There are many 'banned drugs' on the list which are necessary to medically treat various conditions which occur in people. That is why a therapeutic use exemption application exists." — Dr. Neal ElAttrache, to the New York Times, June 2026

This is a real and not-unreasonable point as a general statement about anti-doping policy — TUEs exist precisely because some legitimate medical treatments use substances that are also performance-enhancing in other contexts. Insulin, certain corticosteroids, and ADHD medications are common, uncontroversial examples. The question this post can't resolve on the available record is narrower than the general principle: whether this specific application, for this specific substance, for this specific purpose, was a good-faith fit for that category.

What the Outside Experts Told the Times

The Times reported speaking with ten sports physicians, anti-doping specialists, and trauma surgeons. None said they had heard of a professional athlete previously granted an exemption to use a performance-enhancing drug specifically for bone healing. Dr. David Gerrard — an anti-doping expert who helped WADA establish its own standards for exemption eligibility — was direct:

"I could not recall ever seeing a case or agreeing to any performance-enhancing drug to help heal a broken bone. I cannot think of any banned substance that's proven to help heal bones."

— Dr. David Gerrard, anti-doping standards consultant, to the New York Times

That is a meaningful gap between ElAttrache's general defense of the TUE mechanism and the specific use this application proposed. A TUE process existing for legitimate cases does not establish that this was one — and the people the Times identified as best positioned to know precedent say they don't know of one.

What this post does not claim: that ElAttrache acted in bad faith, or that the consultant's prescription was medically unjustified. ElAttrache says his support was research-based, though he did not cite specific studies to the Times. Two anonymous sources told the paper they believed McGregor sought the exemption as cover for broader performance-enhancing drug use during recovery — an allegation, not an established fact, and not corroborated on the record by anyone willing to be named.

The Procedural Exit

The detail that most changes how this story should be read is what happened after the denial: McGregor did not appeal, litigate, or continue seeking the exemption. He retired. Retirement removed him from USADA's testing pool entirely — a procedural status, not a competitive one, since a retired fighter can return to the pool later, which McGregor did in October 2023.

Whether that sequence reflects a fighter genuinely stepping away during a difficult recovery, or a deliberate use of a procedural off-ramp to recover outside the reach of testing, is exactly the kind of question this record cannot answer with the evidence available. What can be said is that the mechanism — retirement as testing-pool exit — is itself a real structural feature of how these programs work, available to any athlete, used here by one whose timeline invites the question.

The Institution's Response

MLB's interview with ElAttrache was confirmed by multiple outlets as informational, not investigative, with sources stating his role with the Dodgers was "not expected to be impacted." ElAttrache welcomed the conversation publicly: "I look forward to answering whatever questions they may have." This is the same pattern this series flagged in Post 2 — an institution's actual posture running cooler and more procedural than headline coverage suggests, while still leaving the underlying questions about the letter itself unresolved.

The letter didn't break a rule. It asked an institution to bend one, on medical grounds that outside experts say have no real precedent. The next post in this series follows where ElAttrache's signature sits in a much larger pattern — eighteen of the last twenty-nine MVP and Cy Young winners, and what it means when this many careers run through one office.

Primary sources for this post:

• LancasterOnline / Tribune News Service, "Dodgers, Rams physician Neal ElAttrache explains referring UFC star Conor McGregor to steroids specialist," June 2026
• Yahoo Sports / Athlon Sports, "Conor McGregor Accused of Using Banned Drugs for Recovery Ahead of UFC Return," June 12, 2026
• Yahoo Sports, "New York Times slams Conor McGregor for using PEDs to treat broken leg"
• Yahoo Sports / California Post, "MLB to question Dodgers doctor over report he supported Conor McGregor therapeutic PED use"
• DodgerBlue.com, "Dr. Neal ElAttrache Asserts 'Completely Clean' Record Amid Conor McGregor Controversy," June 2026

THE REPAIR ARCHITECTURE · Forensic System Architecture · Post 4 of 7
Randy Gipe & Claude / Anthropic · Trium Publishing House Limited · 2026